Laboratory Valuation
| LH Stock | USD 243.72 3.52 1.42% |
At this time, the firm appears to be undervalued. Laboratory secures a last-minute Real Value of $258.68 per share. The latest price of the firm is $243.72. Our model forecasts the value of Laboratory from analyzing the firm fundamentals such as Return On Equity of 0.0898, profit margin of 0.06 %, and Current Valuation of 26.71 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Laboratory's valuation include:
Price Book 2.475 | Enterprise Value | Enterprise Value Ebitda 14.7534 | Price Sales 1.5481 | Forward PE 15.3139 |
Undervalued
Today
Please note that Laboratory's price fluctuation is very steady at this time. Calculation of the real value of Laboratory is based on 3 months time horizon. Increasing Laboratory's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Laboratory is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Laboratory Stock. However, Laboratory's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 243.72 | Real 258.68 | Target 274.62 | Hype 243.37 | Naive 241.87 |
The intrinsic value of Laboratory's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Laboratory's stock price.
Estimating the potential upside or downside of Laboratory of helps investors to forecast how Laboratory stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Laboratory more accurately as focusing exclusively on Laboratory's fundamentals will not take into account other important factors: When choosing an evaluation method for Laboratory, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Laboratory Cash |
|
Laboratory Valuation Trend
Laboratory's real value analysis enables investors to forecast the earnings more efficiently. Using both Laboratory's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Laboratory Total Value Analysis
Laboratory of is now forecasted to have takeover value of 26.71 B with market capitalization of 20.4 B, debt of 7.27 B, and cash on hands of 430 M. Please note that takeover value may be misleading and is a subject to accounting mistakes. We encourage investors to methodically examine all of the Laboratory fundamentals before making investment evaluation based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
26.71 B | 20.4 B | 7.27 B | 430 M |
Laboratory Investor Information
About 96.0% of the company shares are owned by institutional investors. The book value of Laboratory was now reported as 99.13. The company has Price/Earnings To Growth (PEG) ratio of 0.93. Laboratory recorded earning per share (EPS) of 8.68. The entity last dividend was issued on the 29th of May 2025. The firm had 1164:1000 split on the 3rd of July 2023. Based on the key measurements obtained from Laboratory's financial statements, Laboratory of may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.17 | 0.0835 |
|
| |||||
| Total Cash From Operating Activities | 827.8 M | 1.6 B |
|
| |||||
| Operating Income | 830.3 M | 1.1 B |
|
|
Laboratory Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Laboratory has an asset utilization ratio of 70.78 percent. This signifies that the Company is making $0.71 for each dollar of assets. An increasing asset utilization means that Laboratory of is more efficient with each dollar of assets it utilizes for everyday operations.Laboratory Ownership Allocation
Laboratory maintains a total of 83.7 Million outstanding shares. The majority of Laboratory outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Laboratory of to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Laboratory. Please pay attention to any change in the institutional holdings of Laboratory as this could imply that something significant has changed or is about to change at the company. On July 10, 2025, Representative Ro Khanna of US Congress acquired under $15k worth of Laboratory's common stock.Laboratory Profitability Analysis
The company generated the yearly revenue of 13.01 B. Reported Net Income was 746 M with gross profit of 3.68 B.Laboratory Past Distributions to stockholders
About Laboratory Valuation
An absolute valuation paradigm, as applied to Laboratory Stock, attempts to find the value of Laboratory based on its fundamental and basic technical indicators. By analyzing Laboratory's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Laboratory's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Laboratory. We calculate exposure to Laboratory's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Laboratory's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.5 B | 2 B | |
| Pretax Profit Margin | 0.07 | 0.14 | |
| Operating Profit Margin | 0.08 | 0.17 | |
| Net Profit Margin | 0.06 | 0.07 | |
| Gross Profit Margin | 0.27 | 0.42 |
A single share of Laboratory represents a small ownership stake in the entity. As a stockholder of Laboratory, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Laboratory Dividends Analysis For Valuation
As of now, Laboratory's Dividend Payout Ratio is decreasing as compared to previous years. The Laboratory's current Dividend Paid And Capex Coverage Ratio is estimated to increase to 2.92, while Dividends Paid is forecasted to increase to (230.9 M). . As of now, Laboratory's Price Earnings To Growth Ratio is increasing as compared to previous years.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | -243.1 M | -230.9 M | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | 0.33 | 0.34 | |
| Dividend Paid And Capex Coverage Ratio | 2.16 | 2.92 |
There are various types of dividends Laboratory can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Laboratory shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Laboratory of directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Laboratory pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Laboratory by the value of the dividends paid out.
Laboratory Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 84.4 M | |
| Quarterly Earnings Growth Y O Y | -0.063 | |
| Forward Price Earnings | 15.3139 |
Laboratory Current Valuation Indicators
Valuation refers to the process of determining the present value of Laboratory of and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Laboratory we look at many different elements of the entity such as Laboratory's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Laboratory, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Laboratory's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Laboratory's worth.Complementary Tools for Laboratory Stock analysis
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |